Australia's Cyclopharm sees best day in nearly four months on revenue outlook

Cyclopharm

02/07/2021 02:37

** Cyclopharm Ltd  CYC.AX  gains as much as 7.6% to A$1.775,
marking its biggest intraday percentage rise since March 12
    ** Pharmaceutical co expects total unaudited revenue for H1
FY21 of about A$8.1 mln ($6.05 mln), a 45% rise y/y  urn:newsml:reuters.com:*:nASX4prmg
    ** CYC says first-half dividend expected to be maintained at
0.5 Australian cents per share
    ** CYC down 34% this year, as of last close
($1 = 1.3396 Australian dollars)

 (Reporting by Aditya Munjuluru in Bengaluru)
 ((aditya.srivastsav@thomsonreuters.com))